Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 7Terminated 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Invasive Fungal Infections 1Infections 1Hematologic Neoplasms 1Fusariosis 1Febrile Neutropenia 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Caspofungin × Clear all
NCT00238355 2025-04-27

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

OHSU Knight Cancer Institute

Phase 2 Terminated
13 enrolled 8 charts

Infections

NCT02895529 2019-05-06

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Xian-Janssen Pharmaceutical Ltd.

Phase 4 Terminated
61 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00982540 2014-01-29

Dindexval

Universidade Federal do Rio de Janeiro

Phase NA Terminated
28 enrolled
Classical hematology

Invasive Fungal Infections, Fusariosis, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡